Breaking News
Investing Pro 0
Close

AstraZeneca PLC ADR (AZNPy)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
57.200 -2.200    -3.70%
07:01:00 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US0463531089 
S/N:  886715
  • Volume: 53
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 57.200 - 57.200
AstraZeneca ADR 57.200 -2.200 -3.70%

AZNPy Balance Sheet

 
Featured here, the Balance Sheet for AstraZeneca PLC ADR, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2022
30/09
2022
30/06
2022
31/03
2021
31/12
Total Current Assets 20224 20917 22647 26244
Cash and Short Term Investments 4522 4887 5823 6398
Cash - - - -
Cash & Equivalents 4458 4817 5762 6329
Short Term Investments 64 70 61 53
Total Receivables, Net 10061 9612 9050 8795
Accounts Receivables - Trade, Net 9336 8908 8683 6031
Total Inventory 5078 6220 7624 8983
Prepaid Expenses - - - 1512
Other Current Assets, Total 563 198 150 556
Total Assets 94185 96579 100273 105363
Property/Plant/Equipment, Total - Net 9227 9627 10015 10171
Property/Plant/Equipment, Total - Gross - - - 18495
Accumulated Depreciation, Total - - - -8324
Goodwill, Net 19707 19821 19963 19997
Intangibles, Net 39585 39900 41265 42387
Long Term Investments 1102 1180 1237 1262
Note Receivable - Long Term 725 704 367 2764
Other Long Term Assets, Total 904 994 951 972
Other Assets, Total -920 1016 2980 5143
Total Current Liabilities 24850 21815 22740 22594
Accounts Payable 16842 16983 17040 2824
Payable/Accrued - - - -
Accrued Expenses - - - 12358
Notes Payable/Short Term Debt 743 747 805 411
Current Port. of LT Debt/Capital Leases 5795 2563 2348 2481
Other Current liabilities, Total 1470 1522 2547 4520
Total Liabilities 59031 60628 63914 66076
Total Long Term Debt 24737 28078 29592 30471
Long Term Debt 24069 27393 28868 29717
Capital Lease Obligations 668 685 724 754
Deferred Income Tax 3479 5275 5626 6206
Minority Interest 20 19 19 19
Other Liabilities, Total 846 386 854 2085
Total Equity 35154 35951 36359 39287
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 387 387 387 387
Additional Paid-In Capital 35137 35134 35131 35126
Retained Earnings (Accumulated Deficit) -2471 -1657 -1228 3644
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 2101 2087 2069 130
Total Liabilities & Shareholders' Equity 94185 96579 100273 105363
Total Common Shares Outstanding 1548 1549 1548 1549.4
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AZN Comments

Write your thoughts about AstraZeneca PLC DRC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Neek Kajula
Neek Kajula Mar 24, 2022 9:36AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
did they develop a vaccine that works now or why is thos going up?
Hold This Sheet
Hold This Sheet Sep 23, 2021 2:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Valneva
damian del
mudlog79 Sep 20, 2021 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why this trash going up?
Pascal Torres
Pascal Torres Sep 20, 2021 3:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
speculation
Trader Global
Trader Global Sep 03, 2021 12:04AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
already breakout guy.
Adrian Vanyi
Adrian Vanyi Aug 09, 2021 2:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I would await some further drop based on the below article to come in the near future. The company did not perform well with the vaccine and i opened some short positions if my assumptions are correct.
Adrian Vanyi
Adrian Vanyi Aug 09, 2021 2:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://moneyweek.com/investments/stocks-and-shares/biotech-stocks/603675/astrazenecas-covid-troubles-could-see-it-pull
ray ford
ray ford Jun 30, 2021 8:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hold long = big victory ✌
Leo Mu
Leo Mu Jun 28, 2021 3:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Finally it reached $60+.
Leo Mu
Leo Mu Jun 24, 2021 9:39AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
AZN and MRK: Lynparza approved in China for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer. Support is strong for the 2 stocks.
ray ford
ray ford Jun 20, 2021 2:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
the Delta virus already in USA, but the CDC covered up the truth. in this next 2 weeks, millions of people will get infected, many states may lockdown again.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email